Acetazolamide and Weight increased - a phase IV clinical study of FDA data

Summary:

Weight increased is reported as a side effect among people who take Acetazolamide (acetazolamide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Synthroid, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Weight increased when taking Acetazolamide. It is created by eHealthMe based on reports of 5,933 people who have side effects when taking Acetazolamide from the FDA, and is updated regularly.

What is Acetazolamide?

Acetazolamide has active ingredients of acetazolamide. It is often used in pseudotumor cerebri. eHealthMe is studying from 6,178 Acetazolamide users. Check the latest studies of Acetazolamide.

What is Weight increased?

Weight increased is found to be associated with 2,905 drugs and 3,894 conditions by eHealthMe. Check the latest studies of Weight increased.

On Oct, 20, 2025

5,933 people reported to have side effects when taking Acetazolamide.
Among them, 88 people (1.48%) have Weight increased.

Could Acetazolamide cause Weight increased?

Among these 88 people:

How long have people been on Acetazolamide when they have Weight increased? *

What is the gender of people who have Weight increased when taking Acetazolamide? *

female: 83.12 %
male: 16.88 %

What is the age of people who have Weight increased when taking Acetazolamide? *

What are other drugs people take besides Acetazolamide? *

What are other side effects people have besides Weight increased? *

Fatigue (feeling of tiredness): 36 people, 40.91%
Headache (pain in head): 25 people, 28.41%
Nausea (feeling of having an urge to vomit): 24 people, 27.27%
Chest Pain: 19 people, 21.59%
High Blood Pressure: 19 people, 21.59%
Weakness: 16 people, 18.18%
Joint Pain: 16 people, 18.18%
Urinary Tract Infection: 16 people, 18.18%
Pain: 15 people, 17.05%
Stress And Anxiety: 14 people, 15.91%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 12 people, 13.64%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 7.95%
Immunodeficiency Common Variable: 7 people, 7.95%
Intraocular Pressure Increased: 6 people, 6.82%
Migraine (headache): 5 people, 5.68%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 5.68%
Pain: 5 people, 5.68%
High Blood Cholesterol: 4 people, 4.55%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 4 people, 4.55%
Hypersensitivity: 3 people, 3.41%

* Approximation only. Some reports may have incomplete information.

Do you take Acetazolamide and have Weight increased?

- Check whether Weight increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acetazolamide:

Acetazolamide (6,178 reports)

Weight increased treatments and more:

Weight increased (279,364 reports)

Browse all side effects of Acetazolamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight increased:

Weight increased (2,905 drugs)

Browse all the conditions that are associated with Weight increased:

Weight increased (3,894 conditions)

Related publications that referenced our studies

Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .
Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .

How the study uses the data?

The study uses data from the FDA. It is based on acetazolamide (the active ingredients of Acetazolamide) and Acetazolamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.